Seelos Therapeutics, Inc. (SEELQ)
OTCMKTS · Delayed Price · Currency is USD
0.270
-0.020 (-6.90%)
Dec 20, 2024, 4:00 PM EST

Seelos Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Market Capitalization
014731728436
Upgrade
Market Cap Growth
-98.83%-81.29%-57.68%103.72%133.74%-
Upgrade
Enterprise Value
102864957621
Upgrade
Last Close Price
0.27177.922607.366259.216067.215145.61
Upgrade
PS Ratio
0.016.18---96.30
Upgrade
PB Ratio
-0.06-0.41-6.863.0032.82-5158.84
Upgrade
P/TBV Ratio
---3.0032.82-
Upgrade
EV/Sales Ratio
4.9512.68---55.46
Upgrade
Debt / Equity Ratio
-0.36-0.42-1.900.333.78-
Upgrade
Asset Turnover
0.280.16---0.07
Upgrade
Quick Ratio
0.020.100.629.502.110.95
Upgrade
Current Ratio
0.080.140.9010.072.351.03
Upgrade
Return on Equity (ROE)
---314.84%-220.55%-1489.36%-
Upgrade
Return on Assets (ROA)
-261.11%-179.75%-83.43%-76.33%-82.02%-307.29%
Upgrade
Return on Capital (ROIC)
---103.33%-87.03%-190.81%-
Upgrade
Earnings Yield
17645.41%-278.25%-101.06%-38.41%-22.63%-141.93%
Upgrade
FCF Yield
-777.50%-175.64%-84.66%-28.49%-24.78%-53.46%
Upgrade
Buyback Yield / Dilution
-191.24%-38.20%-17.03%-103.03%--
Upgrade
Total Shareholder Return
-191.24%-38.20%-17.03%-103.03%--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.